Ulf Hanefeld is a Full Professor and Section Leader in the Department of Biotechnology at the Faculty of Applied Sciences , Delft University of Technology (TU Delft) , where he leads the Biocatalysis research section. His work integrates chemistry and biology to develop sustainable synthetic methodologies using enzymes. PhD from Georg-August-Universität zu Göttingen (1993) Postdoctoral experience at Imperial College London, University of Cambridge, and TU Delft Recipient of a Royal Netherlands Academy of Arts and Sciences (KNAW) fellowship His research interests center on biocatalysis , particularly enzymes that enable difficult chemical transformations such as C–C bond formation , enantioselective hydration , and ozonolysis . He focuses on enzyme discovery, engineering, immobilization, and application in flow chemistry to achieve sustainable and efficient synthesis. His work spans from fundamental enzyme mechanism studies to industrial applications in green chemistry . The publication trends reveal a consistent focus on enzyme immobilization , flow reactor systems , and chemo-enzymatic cascades . His recent work emphasizes the use of hydroxynitrile lyases , aldolases , and methyltransferases for the synthesis of chiral intermediates under environmentally benign conditions. The integration of biocatalysis with continuous manufacturing highlights a strong commitment to industrial applicability and process sustainability. Scientific contributions and recognition : Active contributor to high-impact journals in chemistry and biotechnology Coordinated research in the CassaFLOW project (international academic-industrial collaboration) Author of influential reviews, e.g., in Chemical Society Reviews (2022) Teaching and supervision : He teaches Catalysis (Bachelor) and Advanced Biocatalysis (Master), and supervises numerous Master’s theses (MEP) and Bachelor’s projects (BEP) . Students in his group are actively involved in research and often become co-authors on scientific papers. Projects center on green chemistry, enzyme engineering, and spectroscopic analysis of biochemical systems. Laboratory and research environment : The Ulf Hanefeld Group operates within the Biocatalysis section, a multidisciplinary environment fostering collaboration on enzyme discovery, immobilization, and cascade reactions. The group emphasizes practical innovation, with strong links to industry and international research networks.
Pim de Vink is a doctoral researcher at Eindhoven University of Technology , affiliated with the Biomedical Engineering department and Chemical Biology group. Supervised by dr. L.-G. Milroy and prof. L. Brunsveld , his work bridges supramolecular chemistry and chemical biology , focusing on host/guest chemistry for protein complex modulation. Education: B.Sc. in Chemistry (2014) from University of Amsterdam M.Sc. in Biomedical Engineering (2016) from TU/e Internship at Max Planck Institute for Molecular Physiology (2016) on gold-catalyzed synthesis Research Themes: His research develops switchable cucurbituril-based systems for light-controlled enzyme activation and artificial signaling networks. Key areas include protein-protein interaction stabilization , thermodynamic modeling , and allosteric nuclear receptor modulation . Publication Trends: Across JACS , Chemical Science , and RSC Chemical Biology , his work from 2017–2023 emphasizes supramolecular tools for biochemical applications. Notable contributions include 100-fold affinity enhancement of 14-3-3 ligands and UV-responsive cucurbituril release mechanisms . Grants: Funded by Netherlands Organization for Scientific Research (NWO) through Gravity program 024.001.035 and VICI grant 016.150.366.
Wiebe M. de Vos is a Full Professor at the MESA+ Institute, University of Twente, where he leads research in advanced membrane technologies. His work bridges fundamental polymer chemistry and practical applications in water treatment and sustainability. Full Professor, MESA+ Institute, University of Twente His research focuses on membrane science, particularly polyelectrolyte multilayer systems, nanofiltration, and sustainable material design. He investigates how surface chemistry, phase separation, and polymer interactions influence membrane performance in complex aqueous environments. His work addresses critical challenges such as nanoplastics removal, salinity management, and micropollutant degradation. The recent publications highlight a strong trend in developing next-generation membranes with enhanced stability, selectivity, and environmental compatibility. His team explores pH-responsive systems, biocatalytic membranes, and scalable fabrication methods, contributing significantly to both academic knowledge and industrial applications in water purification. No scientific awards were mentioned in the provided text. Dr. de Vos has supervised 22 academic works, indicating active mentorship of Master’s and PhD students. While specific grants are not detailed, his extensive research output and dataset publications suggest sustained funding and collaborative projects. His research integrates experimental design, material characterization, and process engineering. His work is conducted within the MESA+ Institute, a leading nanotechnology research center, fostering interdisciplinary collaboration in materials science and engineering.
Francesca Grisoni serves as an Assistant Professor in the Department of Biomedical Engineering at Eindhoven University of Technology (TU/e), where she currently leads the Molecular Machine Learning team. She additionally holds appointments as an ICMS Core member and Associate Professor at EAISI (Eindhoven Artificial Intelligence Systems Institute), reflecting her cross-disciplinary role at the intersection of computational science and biomedical applications. Academic Background : Grisoni completed her Environmental Sciences degree and earned a Ph.D. in 2016 from the University of Milano-Bicocca, where her dissertation focused on interpretable machine learning for molecular property prediction. During doctoral studies, she conducted research at ETH Zurich's Department of Chemistry and Applied Biosciences and the U.S. EPA's National Center for Computational Toxicology. Ph.D., University of Milano-Bicocca, 2016 (Dissertation: Interpretable machine learning for molecular property prediction) Environmental Sciences, University of Milano-Bicocca Her research integrates artificial intelligence, chemistry, and biology to develop computational methods for drug discovery, emphasizing wet-lab experimental validation alongside algorithmic innovation. Key focus areas include overcoming activity cliffs in molecular machine learning, generative modeling for scaffold hopping, and AI-augmented decision-making in therapeutic development, with the ultimate goal of achieving 'better decisions faster' in drug discovery pipelines. Analysis of her recent 2025 publications reveals a concentrated trend toward chemical language models and generative deep learning frameworks, specifically addressing low-data drug discovery challenges through active learning and neural network architectures. These works bridge computer science with pharmacology, targeting bioactivity prediction, molecular representation, and enzyme design while maintaining strong ties to experimental validation. Scientific Awards : Lush Young Researcher Prize Early Career Award 2022 from the Dutch Royal Netherlands Academy of Arts and Sciences (KNAW) ERC Starting Grant (2022) Grants and Supervision : Dr. Grisoni secured the prestigious ERC Starting Grant in 2022 to advance her molecular machine learning research. Institutional records indicate she has supervised 7 students (as shown in TU/e's 'Supervised Work (7)' repository section), though specific names aren't provided in the source material. Her group maintains active industry collaborations, including past engagement with Bracco Pharmaceuticals. Laboratory and Team : The Molecular Machine Learning team operates under the ICMS and EAISI frameworks, merging computational AI development with experimental wet-lab validation. This collaborative unit focuses on fragment-based molecular design, chirality representation (evidenced by fragSMILES work), and high-throughput nanoparticle identification using machine learning, as highlighted in recent press coverage and datasets.
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Dr. Reuben Leveson-Gower is an Assistant Professor in the Biocatalysis Section of the Department of Biotechnology at TU Delft. His research focuses on designing enzymes for novel chemical reactions, combining synthetic chemistry principles with biological systems to advance green chemistry and deepen understanding of enzyme mechanisms. He holds a PhD from the University of Groningen (cum laude) and has expertise in protein engineering, directed evolution, and computational enzymology. Notable awards include the FEBS Short-Term Fellowship and the Salters’ Institute Graduate Prize. Education: PhD in Chemistry (Groningen), MChem with First Class Honors (Durham). Research Focus: Artificial enzyme design, biocatalytic reactions, protein engineering, and sustainable chemical processes. Awards: FEBS Fellowship, Salters’ Prize, cum laude PhD distinction. His lab employs interdisciplinary techniques such as synthetic chemistry, bioinformatics, and mechanistic enzymology to evolve enzymes for non-natural reactions. Key projects include developing Friedel-Crafts alkylases and boron-catalyzed systems. Collaborations emphasize translational applications in industry and environmental sustainability.
Dorota Kawa is an Assistant Professor at the Faculty of Science, Utrecht University , specializing in Plant Stress Resilience and Experimental and Computational Plant Development . Her research focuses on plant-microbiome interactions, root development under stress, and bioinformatics approaches to enhance crop sustainability. Education : PhD in Plant Physiology and Cell Biology (2017, University of Amsterdam) MSc in Plant Biotechnology (2011, Warsaw University of Life Sciences) BSc in Biotechnology (2010, Warsaw University of Life Sciences) Research Interests span plant adaptation to abiotic stresses, microbiome-driven root cell modifications, and computational modeling of development. She investigates how microbial communities and genetic pathways regulate root metabolomes and cellular traits, particularly under salt and drought stress. Publication Trends show her work centers on Striga resistance in cereal crops, stress-induced root architecture changes , and microbiome-root interactions . She explores auxin-independent signaling and mRNA decay mechanisms to improve multi-stress resilience. Teaching includes courses on plant development and research design at Utrecht University. Her work contributes to Pathways to Sustainability and Future Food initiatives.
Ine van der Fels-Klerx is an Associate Professor in Business Economics at Wageningen University & Research, with a focus on food safety and risk management. She is also a Programme and Account Management lead, overseeing interdisciplinary projects. Her work integrates economic analysis with food safety challenges, particularly addressing mycotoxin contamination, climate change impacts, and circular economy solutions. Key collaborations include projects on early warning systems for mycotoxins and cost-effective monitoring strategies for contaminants in food supply chains. Her research spans topics such as alternative protein sources, insect-based feed production, and resilient supply chain designs. Notable projects include developing decision support tools for risk-based monitoring and assessing the economic feasibility of food safety interventions. She has advised multiple PhD candidates, including those studying mycotoxin management in maize and climate change effects on aflatoxins. Media contributions highlight her expertise in food safety, including interviews on predicting grain contamination and smart monitoring techniques. She actively participates in workshops and conferences, discussing digitalization in food systems and the role of artificial intelligence in food safety prevention.
Professor Gerrit Jan Poelarends is a distinguished academic at the University of Groningen, holding the position of Professor of Pharmaceutical Biotechnology within the Faculty of Science and Engineering. He serves as Director of the Groningen Research Institute of Pharmacy and Head of the Department of Chemical and Pharmaceutical Biology. His extensive research portfolio spans biocatalysis, enzyme engineering, and sustainable pharmaceutical synthesis, with significant contributions to the UN Sustainable Development Goals through environmentally friendly chemical processes. Prof. Poelarends' research interests focus on the discovery and design of novel biocatalysts for pharmaceutical applications. His work centers on developing enzymatic pathways for asymmetric synthesis of noncanonical amino acids, creating enantioselective biocatalysts for various synthetic bond-forming methodologies, and characterizing promiscuous protein functions to understand enzyme evolution. His research group actively explores enzyme engineering guided by mutability landscapes, development of engineered peroxygenases, and discovery of ene- and nitroreductases for sustainable chemistry applications. Analysis of his recent publications reveals a strong trend toward sustainable pharmaceutical synthesis through enzyme engineering, particularly in the areas of nitroreductases, C-N lyases, and peroxygenases. His work consistently bridges fundamental enzymology with practical applications in green chemistry, demonstrating expertise in both understanding enzyme evolution and applying this knowledge to create biocatalysts for environmentally friendly production of pharmaceuticals. His scientific achievements have been recognized through numerous prestigious awards including NWO VENI, VIDI, and VICI grants, ERC Starting and Proof of Concept grants, and competitive fellowships for his students. These awards highlight the innovative nature and impact of his research in biocatalysis and enzyme engineering. Prof. Poelarends has supervised over thirty PhD students throughout his career, with current supervision of multiple doctoral candidates working on projects related to enzyme engineering and biocatalysis. His research has been supported by substantial grants from NWO, the European Union (including multiple ERC grants), and collaborative international projects, reflecting the significance and scope of his work. The Pharmaceutical Biotechnology group he leads includes technicians, postdocs, and PhD students working on various aspects of enzyme discovery and engineering. The research team operates within well-established laboratory facilities at the Groningen Research Institute of Pharmacy, with access to state-of-the-art equipment for protein expression, purification, structural analysis, and biocatalytic reaction screening. Their work is closely integrated with the University of Groningen's broader research initiatives in sustainable chemistry and pharmaceutical sciences, contributing to multiple EU-funded training networks and collaborative projects.
Prof. Roland J. Pieters is a Full Professor of Chemical Biology and Drug Discovery at Utrecht University, leading research in glycodrugs and protein-carbohydrate interactions. He earned his MSc from the University of Groningen (1990) and PhD from MIT (1995), followed by postdoctoral research at ETH Zurich and Utrecht University. His work focuses on multivalent carbohydrate systems targeting bacterial and viral adhesion proteins, including lectins like LecA and Shiga toxin. He has held grants such as the VICI (2008) and a KNAW fellowship (1999), and chairs the Chemical Biology of Multivalent Systems. His research group uses glyco-microarrays and advanced inhibitors to combat pathogens, with applications in vaccines and antivirals. Key achievements include developing polymer-based cholera toxin inhibitors and anti-influenza agents. He contributes to education as a Program Leader in the Pharmaceutical Sciences department and serves on editorial boards, including Molecules (Chemical Biology section). Education: M.Sc., University of Groningen, 1990 Ph.D., MIT, 1995 Research Interests: Glycodrugs, protein-carbohydrate interactions, multivalency, and drug discovery with an emphasis on bacterial/viral adhesion inhibition and immune modulation. His lab designs inhibitors using rigid spacers and explores O-GlcNAc transferase (OGT) inhibitors for therapeutic applications. Grants & Awards: 2023: VICI grant (NWO) 1999: KNAW Fellowship Teaching & Service: Program Leader for Pharmaceutical Sciences education since 2006, member of examination committees, and curriculum developer for Molecular Life Sciences programs. Editorial role in Chemical Biology (Molecules). Labs/Teams: Leads the Chemical Biology and Drug Discovery department, focusing on glycobiology, antiviral strategies, and carbohydrate-based therapeutics.
Arnold J M Driessen is a Professor of Molecular Microbiology at the University of Groningen, within the Faculty of Science and Engineering and the Groningen Biomolecular Sciences and Biotechnology Institute (GBB). He leads the Molecular Microbiology research group, focusing on microbial cell biology, membrane proteins, lipid biosynthesis, and extremophiles. His work bridges fundamental research with biotechnological applications, including biofuel production and antibiotic development. He holds prestigious awards, including the Knight of the Order of the Lion of the Netherlands (2025) and membership in the Royal Netherlands Academy of Arts and Sciences. Driessen has authored nearly 500 publications and 10 patents, supervising 90+ PhD students and 40+ postdocs. His research explores protein translocation, archaeal lipid synthesis, and synthetic cellular systems. Driessen collaborates widely, contributing to public-private partnerships on antibiotic resistance and photopharmacology with Ben Feringa. He has driven the GBB’s international development and serves on committees like the TKI Chemistry Council. His mentorship emphasizes innovation and sustainability, fostering independent research while ensuring project success.
Dr. Caroline E. Paul is an Associate Professor in the Department of Biotechnology at Delft University of Technology (TU Delft) , Faculty of Applied Sciences. She leads an active research group focused on biocatalysis, enzyme engineering, and biomimetic cofactor systems. Education: PhD in Bioorganic Chemistry, University of Oviedo, Spain MSc in Chemical Synthesis and Reactivity, University of Oviedo MSc in Biological Chemistry, University of Toronto Honours BSc in Biological Chemistry, University of Toronto Research Interests: Dr. Paul’s research centers on enzyme discovery and engineering , particularly in flavoprotein monooxygenases and ene reductases. Her group explores biomimetic cofactors to replace natural NAD(P)H, enabling more efficient and sustainable biocatalytic processes. A major focus is the development of one-pot enzymatic cascades for asymmetric synthesis, such as azidohydroxylation and allylic oxidation, with applications in pharmaceutical and fine chemical synthesis. She also investigates metalloproteomics using MIRAGE to study metal distribution in biological systems. Publication Trends: Her recent publications (2020–2024) demonstrate a consistent focus on biocatalytic cascade reactions , cofactor engineering , and enzyme mechanism elucidation . There is a strong emphasis on green chemistry and sustainable synthesis using enzymatic systems. Her work frequently involves the use of biomimetic reductants like BNAH and the integration of photochemical or hydrogen-driven cofactor regeneration. The research bridges fundamental enzymology with practical applications in organic synthesis. Scientific Awards and Grants: ERC Starting Grant (2020) KNCV Gold Medal (2024) Chemistry Europe Fellow (2022–2023) NWO ENW XL Grant (2022) NWO VENI Grant (2015) FP7 Marie Curie Intra-European Fellowship (2013) Delft Technology Fellowship (2018) Advising and Funding: Dr. Paul has successfully secured multiple competitive grants, including from the European Commission (ERC, HORIZON) and the Dutch Research Council (NWO), supporting her research on non-canonical cofactors and biocatalytic cascades. She co-founded NextGenBiocat , an international symposium promoting early-career researchers in biocatalysis, indicating her commitment to mentoring and academic community building. While specific students are not listed, her active funding and group leadership imply ongoing supervision of PhD and postdoctoral researchers. Labs and Teams: She leads the Caroline Paul Group within the Biocatalysis section at TU Delft. Her research involves collaborations with groups across Europe, including Wageningen University, Ruhr-Universität Bochum, and Enzymicals AG. Her lab employs advanced techniques such as isothermal titration calorimetry, stopped-flow spectroscopy, and microsecond freeze-quenching to study enzyme kinetics and mechanisms.
Ilja K. Voets is a Full Professor at Eindhoven University of Technology (TU/e) in the Department of Chemical Engineering and Chemistry, leading the Self-Organizing Soft Matter research group. She is also a Core member of the Institute for Complex Molecular Systems (ICMS). Her academic journey began at Wageningen University & Research where she earned her PhD cum laude in 2008, followed by postdoctoral research at the Aldolphe Merkle Institute in Switzerland. Since 2011, she has been at TU/e, becoming a full professor in 2018. Her educational background includes Molecular Sciences at Wageningen University & Research, with a PhD focusing on micellisation in dilute aqueous solutions of oppositely charged double hydrophilic block copolymers. She was supervised by dr. Arie de Keizer and prof. Martien A. Cohen Stuart. Professor Voets leads an interdisciplinary team of chemists, physicists, biologists, and engineers studying self-assembly processes in biological soft matter. Her research focuses on colloidal self-organization, polymer assembly and folding, and protein biophysics, with particular interest in ice-binding proteins that help organisms survive in extreme cold environments. She investigates how to control intra- and intermolecular copolymer assembly to develop novel functional soft materials, artificial enzymes, and strategies to enhance colloidal stability. A key challenge in her work involves orchestrating colloidal self-assembly with remote cues such as light and temperature. Her recent publications reveal a strong focus on antifreeze proteins, colloidal assembly, and nanoparticle technology, with significant contributions to understanding ice-binding mechanisms and developing novel soft materials. The research demonstrates consistent high-impact output across prestigious journals including PNAS, Angewandte Chemie, and Biomacromolecules. Ambizione Award (2010) : Recognizing early-career research excellence DMS Science and Technology Award (2009) : For significant contributions to materials science ERC Consolidator Grant (2021) : Supporting advanced research in ice-binding protein-polymers Ice-binding protein-polymers project (2016) : Focused on control over ice growth in soft materials Innovative peptide system award (2019) : For novel drug targeting approaches Professor Voets supervises numerous research projects and students, teaching courses including Biological Physics, Physical Chemistry, and Experimental Soft Matter. Her research group is affiliated with the Institute for Complex Molecular Systems, Eindhoven Polymer Laboratories, and the Gravity Program Functional Molecular Systems. Industry collaborations include DSM, Kemetyl, and Unilever, demonstrating the practical applications of her fundamental research. Her work contributes significantly to UN Sustainable Development Goals related to responsible consumption, climate action, and life below water.
Dr. Roger J. Young is Professor and former Associate Dean of Basic Sciences at Saba University School of Medicine. With 30+ years teaching experience, he holds a PhD in Molecular Biology from Texas A&M University. His research develops pedagogical innovations for science education across academic levels. Young has taught diverse student populations including First Peoples communities. Honors include Faculty Excellence and Leadership awards from Drury University. As Course Director for Genetics and Foundations of Clinical Medicine, he promotes active learning strategies. Community engagement includes serving on Saba Hospital's supervisory board. Conference presentations span curriculum design, medical genomics education, and science literacy at venues including Harvard Medical School and Project Kaleidoscope.
